Quality | 2022.12.01
WCG FDAnews Announces: Gene & Cell Therapy Regulation Webinar on December 14, 2022
For drug makers involved in developing gene and cell therapy products, the FDA and other regulators have made it clear: comparability studies are essential to product approval. It is critical that drug makers understand these new requirements in order to avoid minor process changes that could result in quality, efficacy or compliance challenges.
(PRWeb December 01, 2022)
Read the full story at https://www.prweb.com/releases/wcg_fdanews_announces_gene_cell_therapy_regulation_webinar_on_december_14_2022/prweb19049592.htm
For more information, please visit
https://www.prweb.com/releases/wcg_fdane[...]mber_14_2022/prweb19049592.htm
